833_843_
Psychiatr. Pol. 2017; 51(5): 833–843DOI: https://doi.org/10.12740/PP/68917
Karol Grabowski, Katarzyna Nowicka-Sauer,Tomasz Zdrojewski,
Marcin Rutkowski, Piotr Bandosz, Zbigniew Nowicki
FREE POLISH FULLTEXT:
Subiektywna ocena funkcjonowania w ciągu dnia przez osoby cierpiące na bezsenność
FREE ENGLISH FULLTEXT:
Subjective daytime functioning assessment in people with insomnia
Summary
Aim.The aim of this study was to assess the prevalence and severity of subjective daytime functioning impairment among people with insomnia complaints. Another goal was to establish its relationships with age, gender, type and duration of subjective insomnia.
Method. Study group consisted of NATPOL study participants – 2,413 people (1,245 women and 1,168 men) aged18–79. We extracted group with declared insomnia complaints, consisting of 1,221 people (736 women and 485 men) aged 18–79. Data on insomnia symptoms characteristics, their duration and subjective functioning impairment were further analyzed.
Results. Functioning impairment was declared by 825 people (67.7% of those who declared subjective insomnia) and it was more common in women. It was most common among people with insomnia complaints lasting over two weeks – 72.4%. In people with symptoms lasting less than two weeks or for a few days it was 70.7% and 64.9% respectively. People with insomnia symptoms lasting over two weeks accounted for 20% of group with severe functioning impairment. For shorter duration of symptoms it was 8.6% and 6.9% respectively. Among people with mild functioning impairment, persons with symptoms lasting for a few days and less than two weeks were predominant – 32.5% and 35.3% respectively. In people aged 18–24 years mild functioning impairment was predominant (66.66%).
Conclusions. Subjective daytime functioning impairment is common in people declaring insomnia symptoms. It is more common in women and its prevalence and intensity are greater in people with longer duration of sleep problems. Its prevalence is not correlated with age and it is the mildest in people aged 18–24.
ISSN 0033-2674 (PRINT)
ISSN 2391-5854 (ONLINE)
Psychiatria Polska
is an Open Access journal:
Creative Commons: CC-BY
SHERPA RoMEO: Blue
is an Open Access journal:
Creative Commons: CC-BY
SHERPA RoMEO: Blue

Zadanie finansowane
w ramach umowy
nr 739/P-DUN/2018
ze środków MNiSW
przeznaczonych
na działalność
upowszechniającą naukę
KRW PTP dziękuje
firmie PPL – Koral – J.Koral sp.j.
za wsparcie finansowe
udzielone w 2020 roku
Inne strony PTP:
Other PTP websites:
www.psychiatria.org.pl
www.psychiatriapsychoterapia.pl
www.archivespp.pl
www.psychoterapiaptp.pl
Psychiatria Polska
INDEXED IN:
Thomson Reuters Master List
Science Citation Index Expanded
Journal Citation Reports
(Impact Factor 1,596)
Medline/Index Medicus
PubMed/LinkOut
MNiSW (100 pkt)
Scopus/SCImago
CiteScore 2,4
(SJR 0,414; SNIP 0,707)
EMBASE/Excerpta Medica
PsycINFO, EBSCO,
Index Copernicus
Erih Plus, Cochrane Library
CrossRef/DOI
We recommend:
Pharmacological Reports